Psychotropic medication use in parents of survivors of adolescent cancer: A register-based cohort study.

ABSTRACT:

Background

The aim was to investigate psychotropic medication use in parents of survivors of adolescent cancer from the acute post-diagnostic phase and up to 2 years following the cancer diagnosis.

Methods

This study had a nationwide register-based cohort design comparing psychotropic medication use in parents of adolescent survivors of cancer (n = 2323) to use in parents of cancer-free controls (n = 20,868). Cox proportional hazards models, adjusted for cancer diagnostic group, parents' age, country of birth, education level, marital status and previous mental health problems estimated the risk of use from the time of the cancer diagnosis up to 2 years later.

Results

During the first 6 months after the cancer diagnosis, both mothers and fathers had an increased risk

SUBMITTER: Wikman A 

PROVIDER: S-EPMC9678086 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature